Skip to content

Comparision of the double-tract anastomosis and gastric tube anastomosis in proximal gastrectomy for gastric cancer patients: a prospective randomized controlled trial

Comparision of the double-tract anastomosis and gastric tube anastomosis in proximal gastrectomy for gastric cancer patients: a prospective randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004221
Enrollment
Unknown
Registered
2014-01-28
Start date
2014-02-28
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Group A:Double tract anastomosis
Group B:Gastric tube anastomosis

Sponsors

West China Hospital, Sichuan University, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Preoperative endoscopy and biopsy confirmed gastric adenocarcinoma, and predictively proximal gastrectomy; 2. Predictively resectable diseases, either early or locally advanced gastric cancer, of preoperative staging JGCA 14th Edition cT1N0M0-T2N0M0; 3. Aged 18 to 75 years; 4. Without serious disease; 5. Patients without previous history of upper abdominal surgery; 6. WHO performance score <2; 7. Male and female; 8. Informed consent required.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from malignant diseases before the study; 2. Patients with other severe complications cannot tolerate surgery: such as severe heart and lung diseases, heart function below clinical stage 2, uncontrollable hypertension, pulmonary infection, moderate to severe COPD, chronic bronchitis, severe diabetes and / or renal insufficiency, severe hepatitis and / or function below the rank of CHILD B grade, and severe malnutrition, etc.; 3. Patients treated with neoadjuvant chemotherapy or radiation therapy which might affect the efficacy observation; 4. Severity mental diseases; 5. Patients have joined in other Clinical trials and may have influence on the follow-up.

Design outcomes

Primary

MeasureTime frame
Postoperative complications;Reflux symptoms;

Secondary

MeasureTime frame
EORTC QLQ-STO22;EORTC QLQ-C3;

Countries

China

Contacts

Public ContactJian-Kun Hu

Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, China

hujkwch@126.com+86 18980601504

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026